Novel Eczema Drug Ok'd by FDA
6 July 2017 - Two new products have been approved by the FDA for the treatment of eczema. Eucrisa is a topical product that provided a 5% improvement when compared to a placebo over a 4 week period, and will price $600(R7200) a pop for a 60 gram tube. If the patient does not respond to this, there is another newcomer available in injectable form, Dupixent, arriving at a bottom of the barrel price of $37,000 (R444000), and administered every two weeks. At that price you are said to have reduced itch symptoms over a 16 week period, and an improvement of 75% in skin condition.
Now compare this with Axhilirit-E cream and oil for eczema conditions, where all client feedback over the past eight years indicate an immediate relief of itching symptoms, and 90% success in clearing of the condition including treating skin discoloration, at a price ranging from R75 - R290 depending on product and packaging size.
https://www.medpagetoday.com/ClinicalFocus/AtopicDermatitis/66468 https://www.goodrx.com/eucrisa http://www.fiercepharma.com/marketing/sanofi-and-regeneron-s-dupixent-may-be-a-bargain-at-37k http://healing-oil.co.za/online-shop/category/35-axhilirit-e-eczema-cream